Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Urology-Nephrology
»
Neoplasia/BPH
07. May 2026
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Anzeige
Zoom:
Page 1 of 9381
Articles 1 - 20 / 187617
Is Open Partial Nephrectomy Still an Option in the Robotic Era?
Curr Urol Rep
Michael P, Blachman-Braun R, Loebach L, Fu H, Millan B, Saini J, Gurram S, Linehan WM, Ball M.
PMID: 42091753 [PubMed - indexed for MEDLINE]
Diagnostic Challenge in Treatment-Emergent Neuroendocrine Prostate Cancer: A Case Requiring Prostate Rebiopsy After an Inconclusive Metastatic Lung Biopsy.
Intern Med
Nakagaki S, Ito T, Sugiura K, Suzuki H, Morishita T, Taki S, Miyazawa A, Hayashi N, Hibino Y.
PMID: 42091458 [PubMed - as supplied by publisher]
Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-specific Mortality: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Eur Urol
Nguyen DD, Tadayon Najafabadi B, Lin L, Kwong JCC, Miller E, Zlotta AR, Fleshner NE, Hird AE, Lofters AK, Wallis CJD, Rosella LC, Dahm P, Guyatt G, Kulkarni GS.
PMID: 42091407 [PubMed - as supplied by publisher]
Molecular Pathology of Genitourinary Tumors: Diagnostic, Prognostic, and Therapeutic Implications.
Surg Pathol Clin
Cimadamore A, Lopez-Beltran A, Montironi R, Cheng L.
PMID: 42091277 [PubMed - indexed for MEDLINE]
Dutasteride treatment and its effect on standardized uptake values in prostate-specific membrane antigen-PET imaging: A pilot study.
PLoS One
Praetzel L, Burger IA, Rüschoff JH, Rupp NJ, Eberli D, Kranzbühler B.
PMID: 42090407 [PubMed - indexed for MEDLINE]
Face and content validation of laser enucleation of prostate simulation model: an EAU European School of Urology (ESU) Lower Urinary Tract Endoscopy Working Group study.
World J Urol
Sener TE, de Oliveira TR, Demirkiran ED, Perri D, Pereira S, Caballero JP, Osorio L, Kartalas IG, Goossens M, Schoensee B, Dragos L, Veneziano D, Biyani CS, Somani B, Liatsikos E.
PMID: 42090017 [PubMed - indexed for MEDLINE]
Incidence and impact of pseudoprogression and mixed responses in metastatic renal cell carcinoma patients treated with ipilimumab/nivolumab: a retrospective analysis.
Acta Oncol
Caeyman A, Mammone G, Kinget L, Baldewijns M, De Wever L, Albersen M, Debruyne PR, Demeulenaere O, McTaggart ES, Saraswat S, Berghen C, De Meerleer G, Naulaerts S, Garg AD, Beuselinck B.
PMID: 42089693 [PubMed - indexed for MEDLINE]
¹â·â·lu-PSMA-617 radioligand therapy as an immune modulator in prostate cancer.
Expert Rev Anticancer Ther
Sciortino C, Nuzzo A, Stellato M, Claps M, Rametta A, Guadalupi V, Gusmaroli E, Rota S, Mascaro F, Giannatempo P, Zimatore M, Maccauro M, Huber V, Verzoni E, Procopio G.
PMID: 42089687 [PubMed - as supplied by publisher]
Multiparametric MRI in prostate cancer active surveillance: results from the Miami Active Surveillance Trial (MAST) trial.
BJU Int
Sharifi SHH, Williams A, Ryan JT, Ajami T, Nativ OF, Han S, Reis IM, Soodana-Prakash N, Khandekar A, Swain S, Kryvenko ON, Stoyanova R, Pollack A, Castillo PR, Nahar B, Ritch CR, Kava B, Gonzalgo ML, Parekh DJ, Punnen S.
PMID: 42089595 [PubMed - as supplied by publisher]
Multi-omics insights into tumor grade progression in clear cell renal cell carcinoma: from molecular mechanisms to precision therapeutics.
Front Cell Dev Biol
Jena RS, Mishra A.
PMID: 42089114 [PubMed]
Outcomes of pelvic radiotherapy with boost strategies in high nodal-risk prostate cancer: A phase 2 prospective trial.
Clin Transl Radiat Oncol
Thellenberg Karlsson C, Notstam K, Tavelin B, Lundqvist K, Fransson P, Söderkvist K.
PMID: 42088776 [PubMed]
Predicting Prostate Cancer Risk and Its Associated Factors Using Machine Learning Techniques: A Retrospective Study.
Health Sci Rep
Mohammadi S, Imani B, Saeedi S, Amirzargar MA.
PMID: 42088668 [PubMed]
The Brazilian Genome Map Oncology Subproject: a nationwide multicentre hospital-based whole-genome sequencing study of breast, prostate, and colorectal cancer.
Lancet Reg Health Am
Ferreira FO, Rossi BM, Palmero EI, Carvalho Barros LR, Domingos de Nicola P, Monteiro Dos Santos EM, Pereira de Souza J, Thiago de Souza-Santos P, Matta BP, da Silva Sabato C, Braz NC, Monteleone VF, Campacci N, Bastos GM, Guerra TS, Quirino CV, Pereira N, de Oliveira Costa M, Alves da Silva A, Serra AL, Lopes AJ, Alves Coelho BL, Mylla de Aguiar D, Chagas GL, Silva da Costa J, Lima JF, Jaqueline de Souza M, Oliveira SR, da Fonseca C, Cascapera F, Alencar de Moura FA, Perroni Dos Santos G, Guimaraes da Silva L, Campacci L, Sacilotto L, Soares Dos Santos S, Queiroz WDS, Goto GT, Badesso Fonseca TR, De Oliveira Mattoschoell VY, Rosa RO, Sandoval RL, Gambardella DD, Ciconelli RM, Beraldo da Costa Saad M, Guimaraes GC, Collaborative Working Group .
PMID: 42088596 [PubMed]
Real-world incidence of G3-G4 adverse events in patients with advanced renal cell carcinoma receiving immune-combinations (ARON-1).
Front Immunol
Beas-Lozano EL, Scagliarini S, Valdez-Sandoval PI, Esparza-Orozco MF, Bilen MA, Bamias A, Li H, Juan Fita MJ, Kopecky J, Manneh Kopp R, Ghosn M, Fay AP, Bhuva D, Kucharz J, Büttner T, Molina-Cerrillo J, Fiala O, Rizzo A, Maiorano BA, Soares A, Buti S, Marques Monteiro FS, Massari F, Santoni M, Bourlon MT.
PMID: 42088516 [PubMed - indexed for MEDLINE]
Advances in immunotherapy for renal cell carcinoma: a comprehensive review.
Front Immunol
Rajih E, Bakhsh A, Borhan WM, Alqahtani SAM.
PMID: 42088496 [PubMed - indexed for MEDLINE]
The efficacy of neoadjuvant chemohormonal therapy in combination with radical prostatectomy for locally advanced prostate cancer: a systematic review and meta-analysis.
Front Oncol
Luo H, Wang X, He C.
PMID: 42088201 [PubMed]
Clinical performance of the urine-based TERT promoter AbsoluteQ Digital PCR for non-invasive detection of bladder cancer.
Mol Oncol
Nykel A, Kubiak I, Rutkowska L, Kasprzyk , K, Bednarek M, Sobieraj D, Wilkosz J, Kania P, J, Ka, Gach A, Ka.
PMID: 42087419 [PubMed - as supplied by publisher]
Effectiveness and Safety of Interventions for Sarcopenia in Advanced Prostate Carcinoma: Systematic Review.
J Cachexia Sarcopenia Muscle
de Pablos-Rodríguez P, de Armas-Castellano A, Infante-Ventura D, Del Pino-Sedeño T, Domínguez AR, Pedrianes-Martín PB, Calbet JAL, de Pablos-Velasco P, Trujillo-Martín MM.
PMID: 42087380 [PubMed - indexed for MEDLINE]
Psychosocial factors and overall mortality after prostate cancer diagnosis among predominantly low-income Black and White adults.
JNCI Cancer Spectr
Demoulin D, Lipworth L, Aldrich MC, Russo LJ, Munro H, Kolitsopoulos F, Fisa R, Mwala K, Shrubsole MJ, Zheng W, Shu XO.
PMID: 42087336 [PubMed - as supplied by publisher]
The relationship between urethral catheterization before TUR-P and postoperative stricture.
World J Urol
Ataman M, Y, Yufka M, Gürtan E, Yuvanç E.
PMID: 42086950 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 187617
Page 1 of 9381
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy